Title
Process evaluation in the field: Global learnings from seven implementation research hypertension projects in low-and middle-income countries
Date Issued
01 January 2019
Access level
open access
Resource Type
journal article
Author(s)
Limbani F.
Goudge J.
Joshi R.
Maar M.A.
Oldenburg B.
Parker G.
Riddell M.A.
Salam A.
Trieu K.
Thrift A.G.
Van Olmen J.
Vedanthan R.
Webster R.
Yeates K.
Webster J.
Pozas A.F.
Patel A.
Pillay A.
Cotrez B.
Salinas C.A.
Nowson C.
Johnson C.
Villalpando C.G.
Garcia-Ulloa C.
Litzelman D.
Praveen D.
Hua D.
Kakoulis D.
Fottrell E.
Vucovich E.C.
Salazar F.G.
Musa H.
Chemusto H.
Haghparast-Bidgoli H.
Mutabazi J.C.
Schultz J.
Odenkirchen J.
Zavala-Loayza J.
Gyamfi J.
Bobrow K.
Neira L.
Maple-Brown L.
Lazo M.
Daivadanam M.
Wijemanne N.
Almeda-Valdes P.
Camacho-Lopez P.
Delobelle P.
Zhang P.
Saulson R.
Guggilla R.
Kirkham R.
Angeles R.
Mohan S.
Tobe S.
Jha S.
Lei S.
Irazola V.
Ma Y.
Shenderovich Y.
CRÓNICAS, Centro de Excelencia en Enfermedades Crónicas
CRÓNICAS, Centro de Excelencia en Enfermedades Crónicas
Publisher(s)
BioMed Central Ltd.
Abstract
Background: Process evaluation is increasingly recognized as an important component of effective implementation research and yet, there has been surprisingly little work to understand what constitutes best practice. Researchers use different methodologies describing causal pathways and understanding barriers and facilitators to implementation of interventions in diverse contexts and settings. We report on challenges and lessons learned from undertaking process evaluation of seven hypertension intervention trials funded through the Global Alliance of Chronic Diseases (GACD). Methods: Preliminary data collected from the GACD hypertension teams in 2015 were used to inform a template for data collection. Case study themes included: (1) description of the intervention, (2) objectives of the process evaluation, (3) methods including theoretical basis, (4) main findings of the study and the process evaluation, (5) implications for the project, policy and research practice and (6) lessons for future process evaluations. The information was summarized and reported descriptively and narratively and key lessons were identified. Results: The case studies were from low- and middle-income countries and Indigenous communities in Canada. They were implementation research projects with intervention arm. Six theoretical approaches were used but most comprised of mixed-methods approaches. Each of the process evaluations generated findings on whether interventions were implemented with fidelity, the extent of capacity building, contextual factors and the extent to which relationships between researchers and community impacted on intervention implementation. The most important learning was that although process evaluation is time consuming, it enhances understanding of factors affecting implementation of complex interventions. The research highlighted the need to initiate process evaluations early on in the project, to help guide design of the intervention; and the importance of effective communication between researchers responsible for trial implementation, process evaluation and outcome evaluation. Conclusion: This research demonstrates the important role of process evaluation in understanding implementation process of complex interventions. This can help to highlight a broad range of system requirements such as new policies and capacity building to support implementation. Process evaluation is crucial in understanding contextual factors that may impact intervention implementation which is important in considering whether or not the intervention can be translated to other contexts.
Volume
19
Issue
1
Language
English
OCDE Knowledge area
Políticas de salud, Servicios de salud
Scopus EID
2-s2.0-85070506879
PubMed ID
Source
BMC Public Health
ISSN of the container
14712458
Sponsor(s)
Research reported in this publication was supported by the following GACD program funding agencies; National Health and Medical Research Council of Australia (Grant No. 1040178); Medical Research Council of the United Kingdom (Grant No. MR/JO16020/1); Canadian Institutes of Health Research (Grant No. 120389); Grand Challenges Canada (Grant Nos. 0069–04, and 0070–04); International Development Research Centre; Canadian Stroke Network; National Heart, Lung, and Blood Institute of the National Institutes of Health (Grant No. U01HL114200); National Heart, Lung and Blood Institute of the National Institutes of Health (Grant No. 5U01HL114180); National Health and Medical Research Council of Australia (Grant No. 1040030); National Health and Medical Research Council of Australia (Grant No. 1040152). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Funders. The authors declare that the funders did not have a role in the design ... 1Ministry of Science, Technology and Productive Innovation (Argentina), National Health and Medical Research Council (Australia), São Paulo Research Foundation (Brazil), Canadian Institutes of Health Research, Chinese Academy of Medical Sciences, Research & Innovation DG (European Commission), Indian Council of Medical Research, Agency for Medical Research and Development (Japan), The National Institute of Medical Science and Nutrition Salvador Zubiran (Mexico),
Sources of information: Directorio de Producción Científica Scopus